WATCH
It continues to grow and execute and management has delivered, but the market isn't interested in this type of stock. It did a recent acquisition and financial raise. It is building a digital platform for doctors - patient records etc.
Healthcare
WATCH
Management has done a great job of growing the business. It is down because of market concern over debt and credit card balances which continue to rise. However it has managed delinquencies well. The next phase of growth is auto loans. If you own, hold and wait for improvement. He doesn't own but will probably buy it back.
Financial Services
TOP PICK
Its IPO was just over a year ago. Its CEO built up another company and sold it for a ten-fold gain. He is doing the same thing through organic growth and acquisitions. It is trading at 1X revenue but is growing fast so should be 5 to 8X revenue. It is one of his bigger positions. In 2 to 5 years it should hit the radar screen of investors and will probably be sold when it reaches a certain size. Buy 2 Hold 0 Sell 0 (Analysts’ price target is $2.50)
Healthcare
TOP PICK
It is in the Cannabis space in 13 states in the U.S. with 120 retail outlets. It went public at the top of the market and is now at half the valuation compared to its peers. It is cashed up with good profitability. There are a number of catalysts with more states considering legalization. Holds it in the Cannabis portfolio and will probably add more. Buy 11, Hold 0, Sell 0 (Analysts’ price target is $31.57)
0
TOP PICK
People are coming back back to restaurants and entertainment. This is good for Lightspeed since it provides the technology needed. It makes the business more efficient but not at a big expense. It is in full growth mode and should be profitable the year after next. When the sentiment towards the technology sector improves, it should move much higher. He recently added and re-added. It was a toss-up in the office whether to pick Lightspeed or Shopify. He chose Lightspeed because it probably has a little more torque.. Shopify would be a fourth pick. Buy 16, Hold 1 Sell 1 (Analysts’ price target is $54.20)
0